FGFR3 rs121913532: Understanding Skeletal Dysplasia Variants
The variant rs121913532 is a rare genetic change located within the FGFR3 gene. It is clinically significant due to its association with various forms of skeletal dysplasia, which are conditions that affect bone and cartilage development.
What each genotype means
Typical FGFR3 function
This genotype represents the common, non-variant sequence at this position in the FGFR3 gene. It is associated with typical development of the skeletal system as observed in the general population.
This is the most common genotype found in the vast majority of the global population.
Achondroplasia associated variant
This genotype indicates the presence of one copy of the pathogenic variant associated with achondroplasia, a form of skeletal dysplasia. Individuals with this genotype may exhibit clinical features such as disproportionate short stature and limb dysplasia, and should consult with a medical geneticist for clinical monitoring.
This genotype is extremely rare in the general population, occurring in approximately 1 in 20,000 to 30,000 newborns.
Homozygous pathogenic variant
This genotype indicates the presence of two copies of the pathogenic variant, which is associated with a severe and lethal form of skeletal dysplasia. This condition is clinically distinct from the heterozygous form and is characterized by severe respiratory compromise and pulmonary hypoplasia.
This genotype is exceptionally rare and typically occurs only in offspring of two parents who both carry the heterozygous achondroplasia variant.
What is rs121913532 and Where is it Located?
The variant rs121913532 is a specific alteration in the DNA sequence of the FGFR3 gene. In genomics, a SNP (single nucleotide polymorphism) or variant represents a change at a single position in the genetic code. This particular variant is located on chromosome 4, where the FGFR3 gene resides. Because this variant is classified as rare, it is not typically found in the general population at high frequencies. Geneticists study such variants to understand how specific changes in the DNA sequence can disrupt normal biological processes. When a variant occurs in a critical gene like FGFR3, it can alter the instructions for building proteins, potentially leading to changes in how the body develops. Researchers track these variants in clinical databases to help identify the underlying genetic causes of rare developmental conditions.
The Role of the FGFR3 Gene
The FGFR3 gene provides instructions for making a protein called fibroblast growth factor receptor 3. This protein is part of a family of receptors that play a vital role in regulating cell growth, division, and maturation. In the context of skeletal development, FGFR3 acts as a negative regulator of bone growth. It essentially tells the body when to stop the growth of cartilage in the long bones. When the FGFR3 protein is functioning normally, it ensures that bones grow to the appropriate length and shape. However, if the gene contains a variant that causes the receptor to become overactive or constitutively active, it can inhibit bone growth more than it should. This disruption in signaling is the primary mechanism behind several skeletal dysplasias, where the balance between cartilage growth and bone formation is shifted, leading to characteristic physical features.
Research Associations and Evidence Strength
Research has established a strong link between variants in the FGFR3 gene and a spectrum of skeletal disorders, including achondroplasia, hypochondroplasia, and thanatophoric dysplasia. While the specific variant rs121913532 is cataloged as being associated with skeletal dysplasia, the strength of evidence for any single variant can vary based on clinical reporting. Scientific literature indicates that different mutations within the same gene can lead to vastly different clinical outcomes, ranging from mild growth variations to severe, life-threatening skeletal conditions. The clinical significance of these variants is often determined by how they affect the protein's structure and its ability to signal within cells. Because these conditions are rare, ongoing research is essential to refine our understanding of how specific variants like rs121913532 contribute to the clinical presentation of patients observed in medical settings.
Population Frequency and Clinical Context
The variant rs121913532 is considered rare across global populations. In large-scale genomic databases like gnomAD, many pathogenic variants associated with skeletal dysplasias are either absent or present at extremely low frequencies. This rarity is consistent with the nature of these conditions, which are often sporadic or inherited in an autosomal dominant pattern. Because the variant is not common in the general population, it is rarely encountered in routine genetic screening. When identified in a clinical context, it is usually through targeted testing for individuals presenting with specific skeletal features. It is important to note that the presence of a variant does not automatically imply a specific diagnosis, as clinical interpretation requires a comprehensive evaluation by a medical geneticist who can correlate genetic findings with physical examinations and imaging studies.
What You Can and Cannot Do With This Information
Information regarding genetic variants like rs121913532 is intended for educational purposes and should not be used for self-diagnosis or medical decision-making. If you or a family member have received a report mentioning this variant, it is essential to consult with a qualified healthcare professional, such as a genetic counselor or a clinical geneticist. They can provide context based on your specific clinical history and explain what the findings mean for your health or family planning. You cannot use this information to predict health outcomes without professional clinical interpretation. Furthermore, genetic testing results should always be discussed in the context of a formal medical consultation. Avoid making changes to any health management or treatment plans based solely on online information; always rely on the guidance of your medical team to navigate the complexities of genetic health.
How common is this variant?
This variant is classified as rare, with limited representation in large-scale population databases.
Frequently asked questions
What is a skeletal dysplasia?
Skeletal dysplasia refers to a group of conditions that affect the development of bone and cartilage. These conditions can lead to differences in bone growth, resulting in short stature or abnormal bone shapes.
Is rs121913532 always associated with a disease?
Genetic variants are interpreted based on clinical evidence. While this variant is associated with skeletal dysplasia, any clinical significance must be confirmed by a medical professional who can assess the individual's specific health context.
Can I get tested for this variant?
Genetic testing is typically ordered by a physician when there is a clinical reason to suspect a genetic condition. You should discuss the necessity and implications of such testing with a genetic counselor or your doctor.
How are FGFR3-related conditions treated?
Management for skeletal dysplasias is highly individualized and focuses on addressing specific symptoms and complications. Treatment plans are developed by multidisciplinary teams, including orthopedists and geneticists.
Sources & further reading
Educational information only, last refreshed 9/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121913532?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29